Skip to main content
New data suggest there is a huge opportunity for EDs to identify patients with the hepatitis C virus (HCV) and link them into care before downstream complications lead to higher medical costs and adverse outcomes.

ED-based screening programs for hepatitis C (HCV) highlight significant opportunity to identify patients, prevent downstream costs/complications

January 1, 2014

New data suggest there is a huge opportunity for EDs to identify patients with the hepatitis C virus (HCV) and link them into care before downstream complications lead to higher medical costs and adverse outcomes.
Article Limit Reached

You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.

  • Award-winning Medical Content
  • Latest Advances & Development in Medicine
  • Unbiased Content
View Subscription Details

Already have an account? Log in